340 related articles for article (PubMed ID: 3698351)
1. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
[TBL] [Abstract][Full Text] [Related]
2. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
4. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
McConnell KN; Rolton HA; Modi KS; Macdougall AI
Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
[TBL] [Abstract][Full Text] [Related]
5. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
Barton EN; Morgan AG; Burden RP
West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
[TBL] [Abstract][Full Text] [Related]
6. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
Morgan SH; Maher ER; Purkiss P; Watts RW; Curtis JR
Nephrol Dial Transplant; 1988; 3(1):28-32. PubMed ID: 3132636
[TBL] [Abstract][Full Text] [Related]
7. Oxalate removal by differing dialysis techniques.
Dell'Aquila R; Feriani M; Mascalzoni E; Bragantini L; Ronco C; La Greca G
ASAIO J; 1992; 38(4):797-800. PubMed ID: 1450473
[TBL] [Abstract][Full Text] [Related]
8. Serum oxalate in chronic renal failure.
Borland WW; Payton CD; Simpson K; Macdougall AI
Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
[TBL] [Abstract][Full Text] [Related]
9. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
Tomson CR; Channon SM; Parkinson IS; Owen JP; Ward MK; Simpson JM; Laker MF
Nephrol Dial Transplant; 1988; 3(3):295-9. PubMed ID: 3140104
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting low values of serum albumin in CAPD patients.
Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
[TBL] [Abstract][Full Text] [Related]
11. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.
Hoppe B; Graf D; Offner G; Latta K; Byrd DJ; Michalk D; Brodehl J
Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249
[TBL] [Abstract][Full Text] [Related]
12. Urea kinetics evaluation of hemodialysis and CAPD patients.
Acchiardo SR; Kraus AP; LaHatte G; Kaufman PA; Adkins D; Moore LW
Adv Perit Dial; 1992; 8():55-8. PubMed ID: 1361852
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for dietary protein intake in CAPD patients.
Piraino B
Adv Perit Dial; 1996; 12():275-9. PubMed ID: 8865918
[TBL] [Abstract][Full Text] [Related]
15. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
17. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
Tomson CR; Channon SM; Ward MK; Laker MF
Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
[TBL] [Abstract][Full Text] [Related]
18. Nutritional management of dialysis patients: balancing among nutrient intake, dialysis dose, and nutritional status.
Nakao T; Matsumoto H; Okada T; Kanazawa Y; Yoshino M; Nagaoka Y; Takeguchi F
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S133-6. PubMed ID: 12612970
[TBL] [Abstract][Full Text] [Related]
19. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
20. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
